Abstract:Background: Neuroinflammation is a recognized pathological characteristic of neurodegenerative diseases. Spinocerebellar ataxia 13 (SCA13) is a progressive neurodegenerative disease with no effective treatments. Our previous studies reported human mutations in KCNC3 gene are causative for SCA13. Human R423H allelic mutation induces early-onset neurodegeneration and aberrant intracellular retention of Epidermal Growth Factor Receptor (EGFR) in drosophila. However, the neurodegeneration and inflammatory response induced by the R424H allele are unknown in a mammalian model of disease. Method: In this study, a single Kcnc3 R424H mutation (Analogous to the human SCA13 R423H isoform) transgenic mice were created using CRISPR/Cas 9 technique. Motor function (gait, tremor, coordination and balance) and cerebellar volume (scanned and imaged with 7T MRI) of the R424H transgenic mice were evaluated at multiple timepoints. Neurodegeneration (Purkinje cells loss) as well as cerebellar (astroglia, microglia and macrophage activation) and peripheral (plasma cytokines levels) inflammatory responses were examined and analyzed. Result: The R424H transgenic mice showed marked neurological motor dysfunction with high-frequency tremor, aberrant gait, and short latency to fall in Rotarod testing at 3 and 6 months of age. Abnormal spontaneous firing was recorded in electrophysiology of Purkinje cells. Pathological changes in our R424H transgenic mice included progressive Purkinje cell degeneration and cerebellar atrophy. Over-active microglia, astrocytes, and macrophages were observed in the cerebella of transgenic mice. Pearson correlation analyses indicated that the number of Calbindin positive cells, a Purkinje cell marker, showed a strong inverse correlation with the positive cell number of EGFR, phosphorylated EGFR (pEGFR), and CD68. The expression of EGFR/pEGFR was positively correlated with CD68 and Glial Fibrillary Acidic Protein. Conclusion: Transgenic R424H mice provide a novel SCA13 model showing significant motor deficits, Purkinje cells loss, cerebellar inflammation, and atrophy. Our study suggests that the activation of inflammatory immune cells (astroglia, microglia and macrophages) and strong expression of EGFR/ pEGFR signal in these immune cells are associated with Purkinje cell loss in the cerebellum. This abnormal neuroinflammation may play a significant role in the aggressive procession of neurodegeneration.

Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene

Comparison of two families with and without ataxia harboring novel variants in PRKCG

PKCγ mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling

Deregulation of the actin cytoskeleton and macropinocytosis in response to phorbol ester by the mutant protein kinase C gamma that causes spinocerebellar ataxia type 14

Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: Expanding the phenotype

Novel mutation in exon11 of PRKCG (SCA14): A case report

A Familial Late-Onset Hereditary Ataxia Mimicking Pontocerebellar Hypoplasia Caused by A Novel Tsen54 Mutation

Viewpoint: spinocerebellar ataxias as diseases of Purkinje cell dysfunction rather than Purkinje cell loss

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

In Vivo Expression of an SCA27A-linked FGF14 Mutation Results in Haploinsufficiency and Impaired Firing of Cerebellar Purkinje Neurons

Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14

Novel heterozygous PRPH2 variant identified in a patient with spinocerebellar ataxia type 14 and macular dystrophy

SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene

A patient with SCA17 featuring 41 CAG repeats presents with spastic paraplegia and involuntary movement

Spinocerebellar ataxia type 14 (SCA14) in an Argentinian family: a case report

Association of cerebellar inflammation and neurodegeneration in a novel spinocerebellar ataxia type 13 mouse model

Spinocerebellar ataxia type 4 is caused by a GGC expansion in the ZFHX3 gene and is associated with prominent dysautonomia and motor neuron signs

CACNA1G Causes Dominantly Inherited Myoclonus-Ataxia with Intellectual Disability: A Case Report

Polyglutamine spinocerebellar ataxias — from genes to potential treatments

Identification of 46 CAG Repeats Within PPP2R2B As Probably the Shortest Pathogenic Allele for SCA12.